MTND1P29

Across TCGA pan-cancer cohorts, MTND1P29 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MTND1P29 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MTND1P29 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTND1P29 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

BLCA, LIHC, and ESCA are the cancer types where MTND1P29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.908	0.696	.018	36	view →
LIHC	OS	Tertile	All	0.289	0.715	.003	36	view →
ESCA	DFS	Tertile	All	0.249	0.809	.013	27	view →
CESC	DFS	Tertile	II,III,IV	0.098	0.508	.014	18	view →
LUAD	OS	Tertile	III,IV	0.147	0.679	.001	18	view →
UCEC	DFS	Tertile	All	0.817	0.899	.014	18	view →
KIRP	OS	Tertile	III,IV	0.188	0.688	.049	9	view →
STAD	OS	Tertile	II,III,IV	0.598	0.696	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MTND1P29–BLCA (OS)

Open the BLCA breakdown →